ROS1 and non-small cell lung carcinoma: Yamazoe et al. find that short-term (72 h) ROS1-TKI lorlatinib treatment in ROS1-rearranged NSCLC, shows no effect on Lats1 phosphorylation but increases YAP nuclear translocation [90].